Chemours Narrows FY2026 Sales Guidance to $5.924B
Chemours narrowed its FY2026 sales guidance from $5.866B-$6.098B to $5.924B. The headline also cites an estimate of $5.917B.
Related stories
Douglas Dynamics narrows 2026 sales view to $770M-$805M
M impact | EARNINGS | Nov 02, 2026, 11:05 PM UTC
Douglas Dynamics Narrows 2026 Adjusted EPS View to $3–$3.40
Douglas Dynamics narrowed its 2026 adjusted EPS view to $3–$3.40.
M impact | EARNINGS | Nov 02, 2026, 11:05 PM UTC
Douglas Dynamics Q3 Operating Income Was $31.3 Million
M impact | EARNINGS | Nov 02, 2026, 11:03 PM UTC
Cabot Issues Fiscal 2027 Adjusted EPS Guidance of $6.15-$6.75
Cabot’s fiscal 2027 adjusted EPS outlook compares with FactSet consensus of $7.01. Fourth-quarter 2026 adjusted EPS was $1.61 versus $1.55 expected, while revenue was $1.01 billion
M impact | EARNINGS | Nov 02, 2026, 11:03 PM UTC
Oceaneering Sets 2027 EBITDA Guidance at $430M-$480M
Oceaneering expects 2027 free cash flow to exceed 2026 levels, citing strengthening offshore energy markets and higher ROV utilization and pricing.
M impact | EARNINGS | Nov 02, 2026, 11:03 PM UTC
Allison Transmission Reports Q3 2026 Sales of $1.534 Billion, Raises Guidance
Net sales rose 121% year over year, including the acquired Allison Off-Highway business. Adjusted diluted EPS was $2.90 and adjusted EBITDA was $400 million. The company raised ful
M impact | EARNINGS | Nov 02, 2026, 11:03 PM UTC